Immunogenicity of herpes simplex virus type 1 glycoproteins expressed in vaccinia virus recombinants

Barbara A. Blacklaws, S Krishna, Anthony C. Minson, Anthony Nash

Research output: Contribution to journalArticlepeer-review

Abstract / Description of output

Vaccinia virus recombinants expressing glycoproteins B (vgB11), D (VgD52), E (gE/7.5 and gE/4B), G (gG-vac), H (gH-vac), and I (gI-vac) of HSV-1 were used to compare the protective response to these individual glycoproteins in the mouse. Glycoprotein D induced the best neutralizing antibody titers and the most increased rates of HSV clearance from the ear as well as good protection from the establishment of latent HSV infections in the sensory ganglia. Glycoprotein B also induced good neutralizing antibody titers and as great a protection from the establishment of latency as gD although the rate of virus clearance from the ear was not as great as after immunization with gD. Glycoprotein E induced weak neutralizing antibody but gG, gH, and gI did not show a neutralizing antibody response. At higher challenge doses of virus (10(6) PFU HSV-1 in the ear), gE induced a protective response by increasing the rate of virus clearance and reducing the acute infection of ganglia as compared to negative control immunized mice. However there was no protection from the establishment of latent infections after immunization with gE. No protective response was seen to gG, gH, or gl.
Original languageEnglish
Pages (from-to)727-36
Number of pages10
JournalVirology
Volume177
Issue number2
DOIs
Publication statusPublished - Aug 1990

Fingerprint

Dive into the research topics of 'Immunogenicity of herpes simplex virus type 1 glycoproteins expressed in vaccinia virus recombinants'. Together they form a unique fingerprint.

Cite this